Engineered phage endolysin is a potential solution for recurrent bacterial vaginosis
An engineered phage endolysin could offer a highly innovative and precise therapy for recurrent bacterial vaginosis, a disease for which no effective treatment option exists. Data on the novel endolysin targeting Gardnerella, ...
Oct 28, 2020
0
1